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Abstract
This study was undertaken to determine if administration of recombinant bovine interleukin-12 (rBoIL-12) could stimulate a
cellular immune response that protected calves from an oral challenge inoculation with Cryptosporidium parvum oocysts. In a
first experiment, rBoIL-12 intraperitoneally administered as a single dose 1 day before challenge inoculation, did not alter the
course of infection. The percentage of immune competent cells and levels of cytokine gene expression in the ileo-cecal mucosa
and in the draining lymph nodes of treated calves were similar to those of untreated control calves. However, when rBoIL-12 was
subcutaneously administered daily from 2 days before infection to 2 days after infection, a consistent increase of T lymphocytes
and an higher expression of interferon-g (IFN-g) was detected. Again, treatment did not alter the course of infection. Similar
results were obtained when rBoIL-12 was administered daily for 4 days beginning 2 days after oral inoculation. These data
indicate that although rBoIL-12 stimulated a strong immune response in the gut of neonatal calves, the response was not able to
provide protection from challenge inoculation with C. parvum oocysts.
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1. Introduction
Cryptosporidium parvum is a ubiquitous parasitic
protozoan of animals and humans. The infection is
highly prevalent in young livestock and the disease is
usually seen in animals around 2 weeks of age. Clinical
signs are characterized by diarrhea accompanied by
lethargy, fever, dehydration, and poor conditioning
(Fayer et al., 1997). The symptoms, however, can vary
greatly in severity and duration from calf to calf (Fayer
et al., 1998). In addition to its economic importance in
livestock, infected animals can shed a large number of
oocysts into the environment and these oocysts present
a potential risk for human infection.
Most of our present knowledge of the immune
response to C. parvum infection has been derived from
clinical case reports of human infections and studies
using murine models (Riggs, 1997, 2002). From the
murine studies, it has been determined that cell-
mediated immune responses provide greater protection
than humoral responses for recovery from infection.
Both CD4+ T cells and interferon-g (IFN-g) are
essential for protection against C. parvum infection
(Ungar et al., 1991; McDonald et al., 1992; Chen et al.,
1993; McDonald and Bancroft, 1994; Rehg, 1996;
Culshaw et al., 1997; Theodos et al., 1997).
Interleukin-12 (IL-12) is a potent inducer of IFN-g in
a variety of cell types both in vitro (Chan et al., 1991)
and in vivo (Gately et al., 1994). The effect of IL-12 has
been extensively studied in murine models of infection
in response to a broad variety of microorganisms
(reviewed in Romani et al., 1997). Its role in resistance
to experimental infections is ascribed to its proin-
flammatory activity and to the induction of Th1-like
T cell responses (Trinchieri, 1998). In previous studies,
mice treated with IL-12 prior to oral inoculation with
C. parvum oocysts exhibited a significant reduction in
the severity of infection (Urban et al., 1996). These
studies also demonstrated that treatment with IL-12
neutralizing antibodies nullified the beneficial effects of
IL-12 administration.
In cattle, a primary infection with C. parvum
induced an increase in CD4+ and CD8+ T lympho-
cytes in ileal epithelium, and an increase of CD8+ T
lymphocytes in the ileal lamina propria, without
changes in the ileo-cecal lymph nodes (Pasquali et al.,
1997). These changes were associated with a
transcriptional increase in mucosal lymphocyte-
induced IFN-g (Canals et al., 1998). Combined, these
findings strongly suggest that, as in mice, Th1-like
responses develop in cattle in response to C. parvum
infection. As such, the role of IL-12 in the induction of
protective immunity needs to be determined.
The recent availability of the 35 and 40 kDa subunits
of recombinant bovine IL-12 (rBoIL-12) (Zarlenga
et al., 1995a) provided the opportunity to determine if
rBoIL-12 could protect newborn calves from a primary
C. parvum infection similar to that observed in mice.
Different treatment regimens were employed to define
the effects of IL-12 on the immune responses in calves.
2. Materials and methods
2.1. Cytokines
Human recombinant IL-12 (rHuIL-12) was pur-
chased from R&D Systems (Minneapolis, MN, USA).
A single batch of rBoIL-12 (1540 ng/ml) was
produced essentially as described elsewhere and
provided by Schering Plough (Solano-Aguilar et al.,
2002). A unit of biological activity of rBoIL-12
(284 pg) was defined as the amount of IL-12 required
to induce one-half the maximal proliferation of
lymphoblasts induced by the addition of rHuIL-12.
2.2. In vitro studies
2.2.1. Cell preparation
Blood was obtained from healthy 4–8-month-old
cattle by jugular venipuncture and collected in
vacutainer tubes containing EDTA anticoagulant.
Peripheral blood mononuclear cells (PBMC) were
separated on Ficoll (Sigma Chemical, St. Louis, MO,
USA)/Hypaque (Nycomed Inc., Princeton, NJ, USA)
density gradients. Lymphoblasts were generated from
PBMC(1  106 ml1) cultured inRPMI-1640medium
(Sigma Chemical), supplemented with 100 U of
penicillin per ml, 100 mg of streptomicin per ml,
50 ml of kanamycin per ml, 25 mM Hepes, 10 ml of
glutamine per ml, 5  105 mMmercaptoethanol, and
10%heat-inactivated calf serum.Cellsweremaintained
in 162 cm2 cell culture flasks (Costar, Cambridge,MA).
PBMC were stimulated for 3 days in the presence of
Concanavalin A (Con A) (Sigma Chemical) (2.5 mg/
ml). Stimulated PBMC were washed twice with
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calcium-magnesium free Hanks’ balanced salt solution
(HBSS-CMF) (Sigma Chemical) and lymphoblasts
were purified on a Percoll (Pharmacia Biotech,
Uppsala, Sweden) discontinuous density gradient
(25, 40, 50, and 70%), and collected from the interface
between the 40 and the 50% fractions.
2.2.2. Proliferation essays
PBMCwere suspended at a concentration of 4  106
cells per ml in RPMI-1640 and lymphoblasts were
suspended at a concentration of 5  105 cells per ml.
The cells were cultured with rBoIL-12 or rHuIL-12 in
96-well flat-bottomed tissue culture plates. Controls
consisted of cells exposed to a supernate from cells
transfected with control swine poxvirus in the absence
of the IL-12 subunit genes (MBP) at different
concentrations in 96-well flat-bottomed tissue culture
plates (37C, 5% CO2). Lymphoblasts and PBMC were
incubated for 3 or 4 days, respectively. The cells were
harvested 6 h after the addition of 0.5 mCi/well of [3H]
methylthymidine (AmershamLife Science) using a cell
harvester (Cambridge Technology Inc., Watertown,
MA, USA). The amount of [3H] methylthymidine
incorporation was measured by liquid scintillation
counting (Beckman, Fullerton, CA,USA). Background
proliferation was determined by culturing control cells
in the culture media alone. Results are presented as the
mean counts perminute (cpm) of three stimulated wells
minus the mean background counts from unstimulated
cells from three wells.
2.2.3. IFN-g production in vitro
Lymphoblasts were suspended at a concentration of
2  106 cells per ml in RPMI-1640 (supplemented as
previously described). One millilitre of cell suspen-
sion plus 1 ml of RPMI-1640 containing 156 pg/ml of
rBoIL-12 or MBP were incubated in 24-well flat-
bottomed tissue culture plates. After 24, 48, and 72 h,
culture media were collected and the production of
IFN-gwas measured using a commercial ELISA kit as
described by the manufacturer (Mycobacterium
paratuberculosis gamma interferon test kit, IDEXX
Laboratories Inc., Westbrook, ME, USA) per manu-
facturer’s instructions.
2.3. In vivo studies
2.3.1. Parasites and infection
The general experimental design is reported in
Table 1. C. parvum oocysts used in each experiment
were obtained from 1- to 3-week-old Holstein Freisian
calves orally inoculated with the AUCP-1 strain.
Twenty newborn Holstein Freisian male calves were
used in two separate experiments. Calves were housed
indoors in 2 m  3 m isolated pens throughout the
experiments and fed conventional milk replacer twice
daily and water was available ad libitum. In the first
experiment, rBoIL-12 or MBP were given by an
intraperitoneal injection. Eight calves were orally
infected with 1  106 C. parvum oocysts at 2 days of
age and euthanized between 11 and 13 days of age. Of
those, four received intraperitoneal injections (10 ml;
54,225 U; 15.4 mg) of rBoIL-12 at 1 day of age, and
four calves were given 10 ml of MBP. In the second
experiment, rBoIL-12 or the MBP were administered
by subcutaneous injection. Twelve calves were orally
infected with 0.5  106 C. parvum oocysts at 2 days of
age and killed between 11 and 13 days of age. Four
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Table 1
Experimental design
Group Treatment Time of treatment Infection Time of infection Number of
calves
First experiment
1 10 ml of MBPa 1 day of age 1  106 oocysts of C. parvum 2 days of age 4
2 10 ml of rBoIL-12a 1 day of age 1  106 oocysts of C. parvum 2 days of age 4
Second experiment
1 4 ml of MBPb 1–4 days of age 0.5  106 oocysts of C. parvum 2 days of age 4
2 4 ml of rBoIL-12b 1–4 days of age 0.5  106 oocysts of C. parvum 2 days of age 4
3 4 ml of rBoIL-12b 4–7 days of age 0.5  106 oocysts of C. parvum 2 days of age 4
a Treatment (i.p.).
b Treatment (SC).
calves (group 1) were each administered four doses of
4 ml each of MBP at 1–4 days of age, four calves
(group 2) were each administered four doses of 4 ml
(21,690 U, 6.16 mg) of rBoIL-12 at 1–4 days of age,
and the remaining four calves (group 3) were each
given four doses of 4 ml each of rBoIL-12 at 4–7 days
of age. Feces were collected daily from the rectum of
each calf and the number of oocysts, and the severity
of diarrhea was determined as previously described
(Fayer et al., 1998). After euthanizing the calves,
lymph nodes draining the ileum, discrete mesenteric
lymph nodes and an approximately 10 g segment of
ileum just anterior to the continuous ileal Peyer’s
patch were taken from each calf. Ileo-cecal lymph
node (ICLN), intraepithelial (IEL), and lamina propria
(LPL) lymphocytes were isolated as previously
described (Gasbarre, 1994; Pasquali et al., 1997).
Briefly, ICLN were collected by teasing apart the
nodes and removing the debris by sedimentation. IEL
were collected by three incubations in HBSS-CMF
containing 5 mM EDTA on a magnetic stirrer. After
each incubation, media were collected and debris was
eliminated by sedimentation. LPL were collected after
incubation of the remaining tissues three times, with
stirring, in HBSS-CMF containing dispase II neutral
protease (1.5 mg/ml). The IEL and LPL were further
purified by Percoll discontinuous density gradient
centrifugation (40 and 80%). Phenotypic analysis was
performed by indirect immunofluorescence as pre-
viously described (Gasbarre, 1994) using monoclonal
antibodies against bovine CD3, CD4, CD8, IL-2Ralfa,
B-B4, gd, and CD14 (WMRD, Pullman, WA).
2.3.2. Competitive RT-PCR for cytokine gene
expression
Lymphocytes were lysed in 3 ml of guanidinium
isothiocyanate buffer and total RNA was isolated as
previously described (Canals et al., 1998). All samples
were DNAse treated (2.5 UDNase, RNase free; 5 min,
37 8C) in the presence of 80 U of RNase inhibitor to
eliminate contaminating genomic DNA. RNA con-
centration was determined spectrophotometrically and
integrity checked by denaturing agarose gel electro-
phoresis.
Total RNA (5 mg) isolated from the lymphoblasts
was used for the synthesis of cDNA in a reaction
volume of 20 ml in the presence of oligo dT and
Superscript II, (Invitrogen, Gaithersburg, MD). PCR
amplifications were performed in 25 ml, containing
1 ml of cDNA, 0.2 mM of each primer, 10 mM Tris–
HCl (pH 8.3), 1.5 mM MgCl2, 50 mM KCl, 200 mM
dNTP, 0.8 U of Taq DNA polymerase, and a
concentration of plasmid competitor empirically
determined for each experiment. Competitor mole-
cules for bovine cytokines were constructed as
previously described (Zarlenga et al., 1995b). The
size of the amplified products and the primer
information are listed in Table 2. The amplification
program consisted of 35 cycles at 94 8C for 1 min,
55 8C for 1 min, and 72 8C for 2 min. The PCR
products were run on a 1.8% Metaphor: 0.2% GTG
agarose gel and stained with ethidium bromide.
Amplification of hypoxanthine phosphoribosyltrans-
ferase (HPRT) from cDNA in the presence of the
corresponding competitor molecule was used as a
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Table 2
Cytokine competitors, size (bp) of fragment amplified from cDNA and competitor, and forward and reverse primer sequences used in the
competitive RT-PCR
Cytokine competitor Competitor size Primer
IL-2 323 GTACAAGATACAACTCTTGTCTTGC (F)
GTCATTGTTGAGTAGATGCTTTGACAAAAGG (R)
IL-10 465 ATGCATAGCTCAGCACTACTCTGTTGCCTG (F)
TCACTTTTGCATCTTCGTTGTCATGTAGGTT (R)
IFN-g 310 TATGGCCAGGGCCAATTTTTTAGAGAAATA (F)
TTACGTTGATGCTCTCCGGCCTCGAAAGAG (R)
TNF-a 320 CAAGAATTCAGGTCCTCTTCTCAAGCCTCAAGTAAC (F)
TTTGGATCCCGGCAGGTTGATCTCAGCACTGAGG (R)
HPRT 186 GGAGATGATCTCTCAACTTTAACTGG (F)
CATTATAGTCAAGGGCATATCCCAC (R)
control for cDNA synthesis. The cDNAs were
adjusted in order to keep HPRT ratios of cDNA to
competitor approximately equal to 1. Intensities of
fluorescent bands from scanned gels containing
amplified native cDNA were quantified.
2.4. Statistical analysis
Statistical significance was evaluated by a one-way
analysis of variance (ANOVA). Differences were
considered significant when P  0.05.
3. Results
3.1. Effect of rBoIL-12 in vitro
The in vitro biological activity of rBoIL-12 was
assessed by its ability to induce a proliferation in
PBMC and activated Con A lymphoblasts (Fig. 1).
rBoIL-12 induced significant proliferation of lympho-
blasts after 3 days in culture where rHuIL-12, applied
at the same concentration as rBoIL-12, induced a
lower level of stimulation. MBP did not induce any
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Fig. 1. (A) Proliferative response of bovine lymphoblasts stimulated with different concentration of rHuIL-12, rBoIL-12, orMBP (mean CMP of
stimulated wells minus the mean background counts from unstimulated cells) and (B) proliferative response of bovine PBMC stimulated with
rHuIL-12, rBoIL-12, or MBP (mean CMP of stimulated wells minus the mean background counts from unstimulated cells).
proliferation. Both rBoIL-12 and rHuIL-12 demon-
strated a dose-dependent stimulatory effect on PBMC
(Fig. 1). The level of activation, however, was lower
compared to the stimulation observed for lympho-
blasts. MBP did not induce proliferation. IFN-g
production by lymphoblasts cultured for 24, 48, and
72 h with rBoIL-12 or MBP is shown in Fig. 2. rBoIL-
12 induced a dose-dependent IFN-g production
whereas MBP had no effect.
3.2. Effect of rBoIL-12 in vivo
All infected calves began oocyst shedding between
3 and 5 days after oral exposure to oocyst inoculum. In
the first experiment, treatment with a single dose of
rBoIL-12 1 day before oral inoculation with C.
parvum oocysts did not alter the course of infection or
induce measurable immunologic differences, as
defined herein. The percentage cell subsets in IEL,
LPL, and LNL were not different between calves
treated with rBoIL-12 and those treated with MBP
(negative controls). The levels of cytokine expression
were similar between groups and no differences were
seen in terms of diarrhea severity, oocyst shedding
intensity, and duration of infection (data not shown).
In the second experiment, administration of rBoIL-
12 at 1–4 days of age induced a consistent increase of
CD3+, CD4+, and CD8+ T cells in all three tissues
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Fig. 2. IFN-g production of lymphoblasts after stimulation with rBoIL-12 (312 pg/ml).
Table 3
Percentage of intraepithelial (IEL), lamina propria (LPL), and ileo-cecal lymph node (LNL) leukocytes positive for cell surface markers
Groups
IEL LPL LNL
1 2 3 1 2 3 1 2 3
CD3 72.4 (5.6)a 83.4 (0.9)a 82.1 (0.9)a 59.4 (2.3)a 62.5 (3.5)a 74.9 (2.4)b 59.8 (4.5)a 68.9 (3.6)a 72.9 (1.8)b
CD4 5.9 (1.5)a 11.5 (1.7)b 11.6 (3.6)b 3.4 (0.7)a 6.9 (1.7)a 4.0 (0.9)a 38.1 (4.1)a 43.1 (5.0)a 50.1 (2.5)b
CD8 23.0 (2.9)a 32.4 (2.5)b 27.6 (2.0)a 10.8 (1.3)a 12.4 (1.5)a 16.6 (3.2)a 17.5 (2.7)a 21.4 (2.4)a 21.4 (0.9)a
IL2R 22.4 (5.6)a 15.7 (1.6)a 17.7 (6.0)a 14.3 (3.0)a 20.5 (4.3)a 22.6 (5.4)a 15.6 (5.2)a 19.5 (5.8)a 11.8 (0.6)a
gd 5.8 (0.5)a 6.9 (1.3)a 9.1 (1.9)a 3.9 (0.4)a 3.0 (0.6)a 8.2 (2.4)a 8.4 (0.8)a 8.7 (1.6)a 9.7 (0.6)a
B 6.0 (1.4)a 4.9 (1.0)a 6.2 (1.5)a 4.3 (0.8)a 4.4 (0.8)a 4.1 (0.6)a 21.9 (3.3)a 17.8 (2.8)a 18.3 (2.3)a
CD14 4.8 (1.8)a 4.7 (1.0)a 5.1 (1.7)a 1.7 (0.1)a,b 0.9 (0.4)a 3.9 (0.6)b 10.9 (0.6)a 8.3 (1.3)a 11.9 (1.2)a
Values expressed are the mean percentage (S.E.) of different treatment groups. Group 1: calves inoculated with binding protein at 1–4 days of age
(control group); group 2: calves inoculated with rBoIL-12 at 1–4 days of age; group 3: calves inoculated with rBoIL-12 at 4–7 days of age. Values
with no letter in common are significantly different (P  0.05).
examined, although to different degrees (Table 3). Stat-
istically significant differences were seen for the
percentage of CD4+ and CD8+ T cells in the ileal
epithelium of calves treated with rBoIL-12 beginning 1
day before infection (group 2) compared to the percen-
tage of cells from calves treated with MBP (group 1).
There was a significant increase in the percentage of
CD3+Tcells in the lamina propria fromcalves treated at
4–7 days of age with rBoIL-12 beginning 2 days after
infection (group 3) compared to those treatedwithMBP
(group 1) or with rBoIL-12 beginning 1 day before
infection (group 2). Finally, there was a significant
increase in CD3+ and CD4+ T cells in the ileo-cecal
lymph nodes from calves treated with rBoIL-12
beginning 2 days after infection (group 3) compared
to those treated with MBP (group 1) or with rBoIL-12
beginning 1 day before infection (group 2).
Using competitive RT-PCR, a cumulative assess-
ment of cytokine gene expression was obtained from
IEL, LPL, and LNL. All three cell populations showed
detectable levels of expression for the tested
cytokines. In LNL there was a significant increase
of expression of IFN-g in calves in calves treated with
rBoIL-12 beginning 2 days after infection (group 3)
(Fig. 3). IEL and LPL showed substantially higher
expression of mRNA for IFN-g and TNF-a in some
calves treated with rBoIL-12 beginning 1 day before
infection (group 2) although the differences were not
statistically significant (data not shown). The other
cytokines showed similar level of expression in the
tissues examined (data not shown).
The effect of different regimens of rBoIL-12 on the
course of the infection in the different groups of
calves is shown in Table 4. Except for a slight
reduction of oocyst production in calves treated with
rBoIL-12 beginning 1 day before infection (group 2),
the other parameters were similar in all the tested
groups.
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Fig. 3. Cytokine RNA analysis of IFN-g in LNL. Results are expressed as fluorescence intensities ratios of amplified native cDNA to competitor
and normalized to the HPRT values. Individual values (diamonds) and group means (asterisks) are indicated.
Table 4
Prepatent and patent periods of oocyst excretion, oocyst output, and diarrhea in calves treated with rBoIL-12 or MBP and infected with C.
parvum at 2 days of age
Calves
Group 1 Group 2 Group 3
First day oocyst excreted 3.25 (0.5) 3.75 (0.96) 3.75 (0.5)
Days of diarrhea 5.25 (1.5) 4.75 (0.96) 4.00 (2.4)
Oocyst production (106 g1 of feces) 0.94 (0.39) 0.45 (0.1) 1.39 (1.3)
Diarrhea severity index 13.25 (6.3) 10.5 (1.9) 10.0 (6.3)
Values expressed are the mean percentage (S.D.). Group 1: calves inoculated with binding protein at 1–4 days of age (control group); group 2:
calves inoculated with rBoIL-12 at 1–4 days of age; group 3: calves inoculated with rBoIL-12 at 4–7 days of age.
4. Discussion
This study demonstrates for the first time that
rBoIL-12 can stimulate immune response in the
neonatal bovine. Our results clearly demonstrate that
rBoIL-12 exerted biological activity both in vitro and
in vivo. rBoIL-12 induced a dose-dependent prolif-
erative response in resting (PBMC) and activated T
cells (lymphoblasts), and stimulated IFN-g production
in lymphoblasts. These data demonstrate that rBoIL-
12 possesses biological activities similar to that
reported in humans and mice. In addition, adminis-
tration of rBoIL-12 to calves increased the percentage
of T cell populations both in the gut and in the draining
lymph nodes, and increased IFN-g gene expression in
the gut and in the draining lymph nodes of neonatal
calves experimentally infected with C. parvum. The
results reported do not address whether the rBoIL-12
stimulated innate or cognate immune response, but in
other animal models (Grohmann et al., 2001), IL-12
was shown to act in both autocrine and paracrine
responses.
In this study administration of exogenous rBoIL-
12 did not modify the course of an experimental
C. parvum infection. These results are in contrast to
those previously reported which showed that murine
IL-12 was able to induce protection in neonatal mice
(Urban et al., 1996). Themost obvious explanation for
this apparent discrepancy may be the fact that while
cattle and mice share many common features in the
immune response to C. pavum, in cattle IL-12 alone
may be an insufficient stimulator of protective
immunity to C. parvum. Information concerning
the role of cytokines in cattle, and in particular that of
IL-12, is sparse and fragmented. Reports from
experimental studies have described increased IFN-
g production by peripheral blood mononuclear cells
from infected calves stimulated with C. parvum
antigens (de Graaf and Peeters, 1997), an increase in
IFN-gmRNA expression in the mucosa of C. parvum
infected calves (Canals et al., 1998), and a type-1-like
immune response in the gut of calves recovering from
cryptosporidiosis (Wyatt et al., 2001). These results
imply, that similar to murine models, IFN-g is
involved in the immune response to cryptosporidiosis
in cattle. However, little information is available
regarding the specific effects of IL-12 on immuno-
competent cell populations in cattle.
Another reason for the observed lack of protection
after administration of rBoIL-12 could be related to
the timing of the experiment, and it is possible that the
rBoIL-12 was not given at the right time to prevent or
ameliorate the course of the C. parvum development.
In a previous study, the greatest protection from IL-12
in mice was seen when treatment was given 1 day
before infection or the day of the infection to C.
parvum (Urban et al., 1996). Based on these mouse
experiments, calves in the present study were given
rBoIL-12 starting 1 day before infection (group 2), or
2 days after infection (group 3), and both groups
showed substantial changes in the immune response.
In spite of these observed changes, protection may
require a different temporal regimen which must be
determined by a complex dose and time titration.
Such an experiment in cattle is prohibitorily
expensive.
It is interesting to note that calves treated with
rBoIL-12 beginning 2 days after infection (group 3),
which received the last rBoIL-12 treatment 4–6 days
before euthanasia, showed major changes in ICLN.
These modifications were characterized by an
increase in T cells and IFN-g gene expression. In
contrast, calves treated with rBoIL-12 beginning 1
day before infection (group 2), which received the
last inoculation of rBoIL-12 7–9 days before
euthanasia, showed major changes in the gut, and
especially in the lamina propria. These results
suggest that in neonatal calves rBoIL-12 requires
additional time to modify the immune response, and
that the effects of IL-12 are observable initially in
the regional lymph nodes followed later in the
intestinal mucosa. This would indicate that infection
occurred prior to alterations of the intestinal milieu
by the rBoIL-12 treatment. Therefore, it would be
interesting to determine if oral administration of
rBoIL-12 is more effective in stimulating the
mucosal immune response, than parenteral admin-
istration.
Finally, our results imply that IL-12-driven
stimulation of immune responses and IL-12-driven
protection against C. parvum might require vastly
different doses. In the second experiment, where
rBoIL-12 was given for 4 days at a dose of 4 ml daily
(6160 ng/day) there was a stimulation of a predictable
immune response within neonatal calves but this was
insufficient to modify the course of experimental
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infection with C. parvum. The dose given to bovines
was far from equal, relatively to body weight, to that
given to mice, where a dose-dependent effect is
achieved a dose ranging from 200 to 1000 ng. The cost
and difficulty of using a comparable rBoIL-12, make
similar experiments impractical and suggest that
rBoIL-12 maybe better evaluated as an adjuvant for
use in conjunction with antigens to prime a specific
immune response rather than use as a sole immuno-
potentiator.
In conclusion, this report indicates that rBoIL-12
given to neonatal calves can stimulate the immune
system, but that at practical doses, such stimulation is
not able to modify the course of C. parvum infection.
This implies additional information is required to
better understand the role of IL-12 in the immune
system of cattle, and in particular in neonatal calves
that are so highly susceptible to a number of infectious
agents.
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